CS262425B2 - Process for preparing new derivatives of 4-/2-hydroxyethyl/-2-oxetanes - Google Patents

Process for preparing new derivatives of 4-/2-hydroxyethyl/-2-oxetanes Download PDF

Info

Publication number: CS262425B2
Authority: CS; Czechoslovakia
Prior art keywords: group; pyran; tetrahydro; hexyl; formula
Prior art date: 1984-12-21

Application number

CS859016A

Other languages

Czech (cs)

English (en)

Inventor

Pierre Dr Barbier

Fernand Dr Schneider

Ulrich Dr Widmer

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-12-21

Filing date

1985-12-09

Publication date

1989-03-14

1985-12-09 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1989-03-14 Publication of CS262425B2 publication Critical patent/CS262425B2/cs

Links

125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 title claims description 4
238000004519 manufacturing process Methods 0.000 title description 15
-1 2,5-undecadienyl group Chemical group 0.000 claims description 163
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 93
239000007858 starting material Substances 0.000 claims description 69
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 42
150000001875 compounds Chemical class 0.000 claims description 41
239000002253 acid Substances 0.000 claims description 36
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
238000006243 chemical reaction Methods 0.000 claims description 22
125000004432 carbon atom Chemical group C* 0.000 claims description 20
239000001257 hydrogen Substances 0.000 claims description 19
229910052739 hydrogen Inorganic materials 0.000 claims description 19
238000000034 method Methods 0.000 claims description 17
150000007513 acids Chemical class 0.000 claims description 15
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 15
238000002360 preparation method Methods 0.000 claims description 15
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 11
150000003839 salts Chemical class 0.000 claims description 11
125000000217 alkyl group Chemical group 0.000 claims description 10
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 10
VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical group O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 claims description 10
125000001033 ether group Chemical group 0.000 claims description 8
125000006239 protecting group Chemical group 0.000 claims description 8
125000001424 substituent group Chemical group 0.000 claims description 8
150000002431 hydrogen Chemical class 0.000 claims description 7
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 7
229910052717 sulfur Inorganic materials 0.000 claims description 7
229920006395 saturated elastomer Polymers 0.000 claims description 6
125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 6
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
125000004434 sulfur atom Chemical group 0.000 claims description 5
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 4
125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 4
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 4
125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims description 4
229910052760 oxygen Inorganic materials 0.000 claims description 4
239000001301 oxygen Substances 0.000 claims description 4
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 3
125000002252 acyl group Chemical group 0.000 claims description 3
229910052799 carbon Inorganic materials 0.000 claims description 3
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
125000004430 oxygen atom Chemical group O* 0.000 claims description 3
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 2
125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 claims description 2
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 2
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
125000004414 alkyl thio group Chemical group 0.000 claims description 2
125000003277 amino group Chemical group 0.000 claims description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
125000004372 methylthioethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])* 0.000 claims description 2
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
239000011593 sulfur Chemical group 0.000 claims description 2
125000006701 (C1-C7) alkyl group Chemical group 0.000 claims 1
125000001589 carboacyl group Chemical group 0.000 claims 1
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
150000002148 esters Chemical class 0.000 abstract description 46
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 64
239000000243 solution Substances 0.000 description 63
238000001228 spectrum Methods 0.000 description 59
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 57
238000001819 mass spectrum Methods 0.000 description 56
239000000203 mixture Substances 0.000 description 54
HFBHOAHFRNLZGN-LURJTMIESA-N (2s)-2-formamido-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)NC=O HFBHOAHFRNLZGN-LURJTMIESA-N 0.000 description 52
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 52
239000011541 reaction mixture Substances 0.000 description 46
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 45
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 44
239000000741 silica gel Substances 0.000 description 44
229910002027 silica gel Inorganic materials 0.000 description 44
239000002904 solvent Substances 0.000 description 41
230000032050 esterification Effects 0.000 description 37
238000005886 esterification reaction Methods 0.000 description 37
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 32
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
238000004809 thin layer chromatography Methods 0.000 description 22
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 16
IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 15
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 15
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 13
239000000706 filtrate Substances 0.000 description 13
150000001299 aldehydes Chemical class 0.000 description 12
UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 12
238000002329 infrared spectrum Methods 0.000 description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 10
MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 10
238000003756 stirring Methods 0.000 description 10
SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 9
239000012230 colorless oil Substances 0.000 description 9
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 8
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
235000021314 Palmitic acid Nutrition 0.000 description 8
239000003054 catalyst Substances 0.000 description 8
229960000380 propiolactone Drugs 0.000 description 8
238000004587 chromatography analysis Methods 0.000 description 7
238000001816 cooling Methods 0.000 description 7
239000012074 organic phase Substances 0.000 description 7
239000000047 product Substances 0.000 description 7
125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
HFBHOAHFRNLZGN-ZCFIWIBFSA-N (2r)-2-formamido-4-methylpentanoic acid Chemical compound CC(C)C[C@H](C(O)=O)NC=O HFBHOAHFRNLZGN-ZCFIWIBFSA-N 0.000 description 6
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
238000003776 cleavage reaction Methods 0.000 description 6
239000013078 crystal Substances 0.000 description 6
238000005984 hydrogenation reaction Methods 0.000 description 6
KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 6
239000012071 phase Substances 0.000 description 6
230000007017 scission Effects 0.000 description 6
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 5
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-Leucine Natural products CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
102000019280 Pancreatic lipases Human genes 0.000 description 5
108050006759 Pancreatic lipases Proteins 0.000 description 5
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
239000003814 drug Substances 0.000 description 5
229940108623 eicosenoic acid Drugs 0.000 description 5
150000004702 methyl esters Chemical class 0.000 description 5
239000003921 oil Substances 0.000 description 5
235000019198 oils Nutrition 0.000 description 5
229940116369 pancreatic lipase Drugs 0.000 description 5
229910052938 sodium sulfate Inorganic materials 0.000 description 5
235000011152 sodium sulphate Nutrition 0.000 description 5
239000000126 substance Substances 0.000 description 5
150000003462 sulfoxides Chemical class 0.000 description 5
NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 5
SRBATDDRZARFDZ-VKHMYHEASA-N (2s)-2-formamidopropanoic acid Chemical compound OC(=O)[C@H](C)NC=O SRBATDDRZARFDZ-VKHMYHEASA-N 0.000 description 4
201000001320 Atherosclerosis Diseases 0.000 description 4
NSTPXGARCQOSAU-VIFPVBQESA-N N-formyl-L-phenylalanine Chemical compound O=CN[C@H](C(=O)O)CC1=CC=CC=C1 NSTPXGARCQOSAU-VIFPVBQESA-N 0.000 description 4
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 4
229910052786 argon Inorganic materials 0.000 description 4
239000002775 capsule Substances 0.000 description 4
239000000969 carrier Substances 0.000 description 4
229940043279 diisopropylamine Drugs 0.000 description 4
238000000605 extraction Methods 0.000 description 4
HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 4
239000000825 pharmaceutical preparation Substances 0.000 description 4
239000000725 suspension Substances 0.000 description 4
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
MNDIARAMWBIKFW-UHFFFAOYSA-N 1-bromohexane Chemical compound CCCCCCBr MNDIARAMWBIKFW-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 3
239000001828 Gelatine Substances 0.000 description 3
USPFMEKVPDBMCG-LBPRGKRZSA-N N-benzyloxycarbonyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 USPFMEKVPDBMCG-LBPRGKRZSA-N 0.000 description 3
208000008589 Obesity Diseases 0.000 description 3
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
150000008065 acid anhydrides Chemical class 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000009833 condensation Methods 0.000 description 3
230000005494 condensation Effects 0.000 description 3
POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 3
239000000839 emulsion Substances 0.000 description 3
150000002170 ethers Chemical class 0.000 description 3
OAMZXMDZZWGPMH-UHFFFAOYSA-N ethyl acetate;toluene Chemical compound CCOC(C)=O.CC1=CC=CC=C1 OAMZXMDZZWGPMH-UHFFFAOYSA-N 0.000 description 3
125000004494 ethyl ester group Chemical group 0.000 description 3
229920000159 gelatin Polymers 0.000 description 3
239000007903 gelatin capsule Substances 0.000 description 3
235000019322 gelatine Nutrition 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
239000005457 ice water Substances 0.000 description 3
239000000543 intermediate Substances 0.000 description 3
238000002844 melting Methods 0.000 description 3
230000008018 melting Effects 0.000 description 3
235000020824 obesity Nutrition 0.000 description 3
230000002265 prevention Effects 0.000 description 3
238000001953 recrystallisation Methods 0.000 description 3
229910000033 sodium borohydride Inorganic materials 0.000 description 3
239000012279 sodium borohydride Substances 0.000 description 3
ATKQQTNXMNHRCW-KRWDZBQOSA-N tert-butyl 2-[(s)-(4-methylphenyl)sulfinyl]acetate Chemical compound CC1=CC=C([S@@](=O)CC(=O)OC(C)(C)C)C=C1 ATKQQTNXMNHRCW-KRWDZBQOSA-N 0.000 description 3
IONXXIKCTQHZNC-WDSKDSINSA-N (2s,3s)-2-formamido-3-methylpentanoic acid Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC=O IONXXIKCTQHZNC-WDSKDSINSA-N 0.000 description 2
SMWRPBBMZSLPFD-MRTLOADZSA-N (3r)-3-(oxan-2-yloxy)tetradecanal Chemical compound CCCCCCCCCCC[C@H](CC=O)OC1CCCCO1 SMWRPBBMZSLPFD-MRTLOADZSA-N 0.000 description 2
LRXRIVSWHMVULO-NYLDSWQDSA-N (3r)-3-hexyl-4-hydroxy-6-undecyloxan-2-one Chemical compound CCCCCCCCCCCC1CC(O)[C@@H](CCCCCC)C(=O)O1 LRXRIVSWHMVULO-NYLDSWQDSA-N 0.000 description 2
LRXRIVSWHMVULO-HKBOAZHASA-N (3s,4s,6r)-3-hexyl-4-hydroxy-6-undecyloxan-2-one Chemical compound CCCCCCCCCCC[C@@H]1C[C@H](O)[C@H](CCCCCC)C(=O)O1 LRXRIVSWHMVULO-HKBOAZHASA-N 0.000 description 2
RFUMHDPVUAYHGC-JBBSUMMASA-N (z,2s,3s,5r)-2-ethyl-3-hydroxy-5-(oxan-2-yloxy)docos-13-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCC[C@H](C[C@H](O)[C@H](CC)C(O)=O)OC1CCCCO1 RFUMHDPVUAYHGC-JBBSUMMASA-N 0.000 description 2
WHNQTHDJEZTVHS-UHFFFAOYSA-N 3-(1,3-benzothiazol-2-yl)propanoic acid Chemical compound C1=CC=C2SC(CCC(=O)O)=NC2=C1 WHNQTHDJEZTVHS-UHFFFAOYSA-N 0.000 description 2
SMWRPBBMZSLPFD-UHFFFAOYSA-N 3-(oxan-2-yloxy)tetradecanal Chemical compound CCCCCCCCCCCC(CC=O)OC1CCCCO1 SMWRPBBMZSLPFD-UHFFFAOYSA-N 0.000 description 2
XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 2
VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
206010003210 Arteriosclerosis Diseases 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
239000003810 Jones reagent Substances 0.000 description 2
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
PYUSHNKNPOHWEZ-YFKPBYRVSA-N N-formyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC=O PYUSHNKNPOHWEZ-YFKPBYRVSA-N 0.000 description 2
UGJBHEZMOKVTIM-UHFFFAOYSA-N N-formylglycine Chemical compound OC(=O)CNC=O UGJBHEZMOKVTIM-UHFFFAOYSA-N 0.000 description 2
OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
235000021355 Stearic acid Nutrition 0.000 description 2
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 2
PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 2
239000004480 active ingredient Substances 0.000 description 2
229960003767 alanine Drugs 0.000 description 2
230000001476 alcoholic effect Effects 0.000 description 2
230000029936 alkylation Effects 0.000 description 2
238000005804 alkylation reaction Methods 0.000 description 2
208000011775 arteriosclerosis disease Diseases 0.000 description 2
CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 2
FWBUJEHTZIEJAD-XLEWBJRTSA-N benzyl (2s,3s,5r)-2-hexyl-3-hydroxy-5-(oxan-2-yloxy)hexadecanoate Chemical compound O=C([C@@H](CCCCCC)[C@@H](O)C[C@@H](CCCCCCCCCCC)OC1OCCCC1)OCC1=CC=CC=C1 FWBUJEHTZIEJAD-XLEWBJRTSA-N 0.000 description 2
AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
239000012043 crude product Substances 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 description 2
239000008298 dragée Substances 0.000 description 2
239000003480 eluent Substances 0.000 description 2
239000012259 ether extract Substances 0.000 description 2
238000006266 etherification reaction Methods 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
239000003925 fat Substances 0.000 description 2
235000019197 fats Nutrition 0.000 description 2
235000013305 food Nutrition 0.000 description 2
VGGRCVDNFAQIKO-UHFFFAOYSA-N formic anhydride Chemical compound O=COC=O VGGRCVDNFAQIKO-UHFFFAOYSA-N 0.000 description 2
GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
150000004678 hydrides Chemical class 0.000 description 2
229960003136 leucine Drugs 0.000 description 2
ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
229910003446 platinum oxide Inorganic materials 0.000 description 2
229920005862 polyol Polymers 0.000 description 2
150000003077 polyols Chemical class 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 2
238000007127 saponification reaction Methods 0.000 description 2
238000010898 silica gel chromatography Methods 0.000 description 2
235000017557 sodium bicarbonate Nutrition 0.000 description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
ATKQQTNXMNHRCW-QGZVFWFLSA-N tert-butyl 2-[(r)-(4-methylphenyl)sulfinyl]acetate Chemical compound CC1=CC=C([S@](=O)CC(=O)OC(C)(C)C)C=C1 ATKQQTNXMNHRCW-QGZVFWFLSA-N 0.000 description 2
FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 2
BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 2
125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
VEPTXBCIDSFGBF-UHFFFAOYSA-M tetrabutylazanium;fluoride;trihydrate Chemical compound O.O.O.[F-].CCCC[N+](CCCC)(CCCC)CCCC VEPTXBCIDSFGBF-UHFFFAOYSA-M 0.000 description 2
HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 2
229940117972 triolein Drugs 0.000 description 2
229940005605 valeric acid Drugs 0.000 description 2
LEAJNQBUKCXJJK-HZJYTTRNSA-N (13z,16z)-2-benzyl-3-hydroxy-5-(oxan-2-yloxy)docosa-13,16-dienoic acid Chemical compound C1CCCOC1OC(CCCCCCC\C=C/C\C=C/CCCCC)CC(O)C(C(O)=O)CC1=CC=CC=C1 LEAJNQBUKCXJJK-HZJYTTRNSA-N 0.000 description 1
LPXUCBMFPYJSFL-UFUNBNSISA-N (2r)-2-[1-hydroxy-3-(oxan-2-yloxy)butyl]octadecanoic acid Chemical compound CCCCCCCCCCCCCCCC[C@@H](C(O)=O)C(O)CC(C)OC1CCCCO1 LPXUCBMFPYJSFL-UFUNBNSISA-N 0.000 description 1
IBNYAIKYXDLAGF-PYEOEOCKSA-N (2r)-2-[1-hydroxy-3-(oxan-2-yloxy)butyl]octanoic acid Chemical compound CCCCCC[C@@H](C(O)=O)C(O)CC(C)OC1CCCCO1 IBNYAIKYXDLAGF-PYEOEOCKSA-N 0.000 description 1
CGZVOMDVSQKYRZ-YQEOXULRSA-N (2r)-2-[1-hydroxy-3-(oxan-2-yloxy)hept-6-enyl]dodecanoic acid Chemical compound CCCCCCCCCC[C@@H](C(O)=O)C(O)CC(CCC=C)OC1CCCCO1 CGZVOMDVSQKYRZ-YQEOXULRSA-N 0.000 description 1
REYXSTWBFWDURU-UFUNBNSISA-N (2r)-2-hexyl-3-hydroxy-5-(oxan-2-yloxy)hexadecanoic acid Chemical compound CCCCCCCCCCCC(CC(O)[C@@H](CCCCCC)C(O)=O)OC1CCCCO1 REYXSTWBFWDURU-UFUNBNSISA-N 0.000 description 1
XUYDFFRPYIVZQB-ZETCQYMHSA-N (2s)-2-[formyl(methyl)amino]-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)N(C)C=O XUYDFFRPYIVZQB-ZETCQYMHSA-N 0.000 description 1
REYXSTWBFWDURU-VHNWMKGBSA-N (2s,3s,5r)-2-hexyl-3-hydroxy-5-(oxan-2-yloxy)hexadecanoic acid Chemical compound CCCCCCCCCCC[C@H](C[C@H](O)[C@H](CCCCCC)C(O)=O)OC1CCCCO1 REYXSTWBFWDURU-VHNWMKGBSA-N 0.000 description 1
YHIWWXWYSLDVQS-AKYHMYKESA-N (2s,3s,5s)-2-ethyl-3-hydroxy-5-(oxan-2-yloxy)docosanoic acid Chemical compound CCCCCCCCCCCCCCCCC[C@@H](C[C@H](O)[C@H](CC)C(O)=O)OC1CCCCO1 YHIWWXWYSLDVQS-AKYHMYKESA-N 0.000 description 1
LTDOPTVIIUBRNB-VEDVMXKPSA-N (3r)-3-(oxan-2-yloxy)butanal Chemical compound O=CC[C@@H](C)OC1CCCCO1 LTDOPTVIIUBRNB-VEDVMXKPSA-N 0.000 description 1
NBQZCFRUPXJXQR-JHJMLUEUSA-N (3r)-3-(oxan-2-yloxy)hept-6-enal Chemical compound C=CCC[C@H](CC=O)OC1CCCCO1 NBQZCFRUPXJXQR-JHJMLUEUSA-N 0.000 description 1
TYBPYMSSRRRYRQ-GFOWMXPYSA-N (3r)-3-hexyl-6-undecyloxane-2,4-dione Chemical class CCCCCCCCCCCC1CC(=O)[C@@H](CCCCCC)C(=O)O1 TYBPYMSSRRRYRQ-GFOWMXPYSA-N 0.000 description 1
FGRMZDNDNMUTII-RDBSUJKOSA-N (3s,4s)-3-hexyl-4-[(2r)-2-hydroxyhex-5-enyl]oxetan-2-one Chemical compound CCCCCC[C@H]1[C@H](C[C@H](O)CCC=C)OC1=O FGRMZDNDNMUTII-RDBSUJKOSA-N 0.000 description 1
FYWXDCNWSQOUEW-JKKRJZFWSA-N (3s,4s)-3-hexyl-4-[(2r,10z,13z)-2-hydroxynonadeca-10,13-dienyl]oxetan-2-one Chemical compound CCCCCC[C@H]1[C@H](C[C@H](O)CCCCCCC\C=C/C\C=C/CCCCC)OC1=O FYWXDCNWSQOUEW-JKKRJZFWSA-N 0.000 description 1
VSJZYCXVQANSKF-XHSDSOJGSA-N (3s,4s)-4-[(2r)-2-hydroxytridecyl]-3-methyloxetan-2-one Chemical compound CCCCCCCCCCC[C@@H](O)C[C@@H]1OC(=O)[C@H]1C VSJZYCXVQANSKF-XHSDSOJGSA-N 0.000 description 1
SADDCMOSKFSCRX-ZNZIZOMTSA-N (3s,4s,6r)-4-[tert-butyl(dimethyl)silyl]oxy-3-hexyl-6-undecyloxan-2-one Chemical compound CCCCCCCCCCC[C@@H]1C[C@H](O[Si](C)(C)C(C)(C)C)[C@H](CCCCCC)C(=O)O1 SADDCMOSKFSCRX-ZNZIZOMTSA-N 0.000 description 1
NKGZHGDRURDBMP-GEPVFLLWSA-N (5R)-2-hexyl-3-hydroxy-5-(oxan-2-yloxy)hexadec-2-enoic acid Chemical compound CCCCCCCCCCC[C@H](CC(O)=C(CCCCCC)C(O)=O)OC1CCCCO1 NKGZHGDRURDBMP-GEPVFLLWSA-N 0.000 description 1
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
ADLXTJMPCFOTOO-BQYQJAHWSA-N (E)-non-2-enoic acid Chemical compound CCCCCC\C=C\C(O)=O ADLXTJMPCFOTOO-BQYQJAHWSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
HVGRZDASOHMCSK-UHFFFAOYSA-N (Z,Z)-13,16-docosadienoic acid Natural products CCCCCC=CCC=CCCCCCCCCCCCC(O)=O HVGRZDASOHMCSK-UHFFFAOYSA-N 0.000 description 1
USVVENVKYJZFMW-ONEGZZNKSA-N (e)-carboxyiminocarbamic acid Chemical compound OC(=O)\N=N\C(O)=O USVVENVKYJZFMW-ONEGZZNKSA-N 0.000 description 1
ATNNLHXCRAAGJS-QZQOTICOSA-N (e)-docos-2-enoic acid Chemical compound CCCCCCCCCCCCCCCCCCC\C=C\C(O)=O ATNNLHXCRAAGJS-QZQOTICOSA-N 0.000 description 1
DZQKTKXCRZFDLC-HPWOKYPUSA-N (z,3r)-3-(oxan-2-yloxy)icos-11-enal Chemical compound CCCCCCCC\C=C/CCCCCCC[C@H](CC=O)OC1CCCCO1 DZQKTKXCRZFDLC-HPWOKYPUSA-N 0.000 description 1
WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
DHDRGOURKDLAOT-UHFFFAOYSA-N 1-formylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)C1CCCN1C=O DHDRGOURKDLAOT-UHFFFAOYSA-N 0.000 description 1
238000005160 1H NMR spectroscopy Methods 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
SWFIIKIRSJKTSX-UHFFFAOYSA-N 2-ethyl-3-hydroxy-5-(oxan-2-yloxy)hexadecanoic acid Chemical compound CCCCCCCCCCCC(CC(O)C(CC)C(O)=O)OC1CCCCO1 SWFIIKIRSJKTSX-UHFFFAOYSA-N 0.000 description 1
REYXSTWBFWDURU-UHFFFAOYSA-N 2-hexyl-3-hydroxy-5-(oxan-2-yloxy)hexadecanoic acid Chemical compound CCCCCCCCCCCC(CC(O)C(CCCCCC)C(O)=O)OC1CCCCO1 REYXSTWBFWDURU-UHFFFAOYSA-N 0.000 description 1
RPQVTRQMZUOWNF-UHFFFAOYSA-N 2-hexyl-3-hydroxy-5-(oxan-2-yloxy)non-8-enoic acid Chemical compound CCCCCCC(C(O)=O)C(O)CC(CCC=C)OC1CCCCO1 RPQVTRQMZUOWNF-UHFFFAOYSA-N 0.000 description 1
125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 1
RDBJBXDOLANDIM-UHFFFAOYSA-N 3-(oxan-2-yloxy)tetradecan-1-ol Chemical compound CCCCCCCCCCCC(CCO)OC1CCCCO1 RDBJBXDOLANDIM-UHFFFAOYSA-N 0.000 description 1
QWLHJVDRPZNVBS-UHFFFAOYSA-N 4-phenoxybenzaldehyde Chemical compound C1=CC(C=O)=CC=C1OC1=CC=CC=C1 QWLHJVDRPZNVBS-UHFFFAOYSA-N 0.000 description 1
JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 description 1
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
229910000761 Aluminium amalgam Inorganic materials 0.000 description 1
235000021357 Behenic acid Nutrition 0.000 description 1
DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
OKJADYKTJJGKDX-UHFFFAOYSA-N Butyl pentanoate Chemical compound CCCCOC(=O)CCCC OKJADYKTJJGKDX-UHFFFAOYSA-N 0.000 description 1
ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
JBCWAAAEBXHFJW-WWFYNWEGSA-N C(CCCCC)[C@@H](C(=O)O)C(CC(CCC=CCCCCCC)OC1OCCCC1)O Chemical compound C(CCCCC)[C@@H](C(=O)O)C(CC(CCC=CCCCCCC)OC1OCCCC1)O JBCWAAAEBXHFJW-WWFYNWEGSA-N 0.000 description 1
KPMIEHHDSIIQMQ-VTBWFHPJSA-N CCCCCCC(C(O)=O)=C(O)C[C@@H](CCCC)OC1CCCCO1 Chemical compound CCCCCCC(C(O)=O)=C(O)C[C@@H](CCCC)OC1CCCCO1 KPMIEHHDSIIQMQ-VTBWFHPJSA-N 0.000 description 1
RVCPOFGMXITPGO-MRTLOADZSA-N CCCCCCCC=CCC[C@H](CC=O)OC1CCCCO1 Chemical compound CCCCCCCC=CCC[C@H](CC=O)OC1CCCCO1 RVCPOFGMXITPGO-MRTLOADZSA-N 0.000 description 1
GBWCGRXZMIHQOP-PPUHSXQSSA-N CCCCCCCCCCC(C(O)=O)=C(O)C[C@@H](CCCC)OC1CCCCO1 Chemical compound CCCCCCCCCCC(C(O)=O)=C(O)C[C@@H](CCCC)OC1CCCCO1 GBWCGRXZMIHQOP-PPUHSXQSSA-N 0.000 description 1
NCGOQGJVJMZYKO-HDXUUTQWSA-N CCCCC\C=C/C\C=C/CCCCCCCC(CC(O)C(CC)C(=O)OC(C)(C)C)OC1CCCCO1 Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(CC(O)C(CC)C(=O)OC(C)(C)C)OC1CCCCO1 NCGOQGJVJMZYKO-HDXUUTQWSA-N 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
208000031226 Hyperlipidaemia Diseases 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-Valine Natural products CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
235000019454 L-leucine Nutrition 0.000 description 1
239000004395 L-leucine Substances 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
WXNXCEHXYPACJF-ZETCQYMHSA-M N-acetyl-L-leucinate Chemical compound CC(C)C[C@@H](C([O-])=O)NC(C)=O WXNXCEHXYPACJF-ZETCQYMHSA-M 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
YZVDYHHJNQLXED-USTNKWEJSA-N O([C@@H](C[C@H](O)CC(=O)OC(C)(C)C)C=1C=CC(OC=2C=CC=CC=2)=CC=1)C1CCCCO1 Chemical compound O([C@@H](C[C@H](O)CC(=O)OC(C)(C)C)C=1C=CC(OC=2C=CC=CC=2)=CC=1)C1CCCCO1 YZVDYHHJNQLXED-USTNKWEJSA-N 0.000 description 1
KMIRXILKFYIZGO-BQCAGXOESA-N O[C@@H](C(C(=O)OC(C)(C)C)[S@@](=O)C1=CC=C(C=C1)C)CCCCCCC\C=C/C\C=C/CCCCC Chemical compound O[C@@H](C(C(=O)OC(C)(C)C)[S@@](=O)C1=CC=C(C=C1)C)CCCCCCC\C=C/C\C=C/CCCCC KMIRXILKFYIZGO-BQCAGXOESA-N 0.000 description 1
239000005642 Oleic acid Substances 0.000 description 1
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
229920002807 Thiomer Polymers 0.000 description 1
238000007239 Wittig reaction Methods 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
239000013543 active substance Substances 0.000 description 1
231100000369 acute toxicity data Toxicity 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
150000008044 alkali metal hydroxides Chemical class 0.000 description 1
229910052784 alkaline earth metal Inorganic materials 0.000 description 1
150000001342 alkaline earth metals Chemical class 0.000 description 1
125000003545 alkoxy group Chemical group 0.000 description 1
125000005907 alkyl ester group Chemical group 0.000 description 1
150000001350 alkyl halides Chemical class 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
235000019270 ammonium chloride Nutrition 0.000 description 1
150000008064 anhydrides Chemical class 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000012300 argon atmosphere Substances 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
239000002585 base Substances 0.000 description 1
229940116226 behenic acid Drugs 0.000 description 1
YPDPKOLRRHVBNL-LIMHNSPMSA-N benzyl (2s,3s,5r)-3-[tert-butyl(dimethyl)silyl]oxy-2-hexyl-5-(oxan-2-yloxy)hexadecanoate Chemical compound O=C([C@@H](CCCCCC)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@@H](CCCCCCCCCCC)OC1OCCCC1)OCC1=CC=CC=C1 YPDPKOLRRHVBNL-LIMHNSPMSA-N 0.000 description 1
WLTYLNJVIIEJLA-CEUYOYMZSA-N benzyl (2s,3s,5r)-3-[tert-butyl(dimethyl)silyl]oxy-2-hexyl-5-hydroxyhexadecanoate Chemical compound CCCCCCCCCCC[C@@H](O)C[C@H](O[Si](C)(C)C(C)(C)C)[C@H](CCCCCC)C(=O)OCC1=CC=CC=C1 WLTYLNJVIIEJLA-CEUYOYMZSA-N 0.000 description 1
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
230000037396 body weight Effects 0.000 description 1
239000012267 brine Substances 0.000 description 1
239000000872 buffer Substances 0.000 description 1
235000014121 butter Nutrition 0.000 description 1
QPQYEVGNYFEEFX-BJYSPHJKSA-N butyl (3R)-3-hydroxy-5-(oxan-2-yloxy)hexadecanoate Chemical compound O[C@@H](CC(=O)OCCCC)CC(CCCCCCCCCCC)OC1OCCCC1 QPQYEVGNYFEEFX-BJYSPHJKSA-N 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000011575 calcium Substances 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
235000019219 chocolate Nutrition 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
229930016911 cinnamic acid Natural products 0.000 description 1
235000013985 cinnamic acid Nutrition 0.000 description 1
229940117916 cinnamic aldehyde Drugs 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
239000000470 constituent Substances 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
RNOJZAYWQCKGRK-UHFFFAOYSA-N diazene hydrochloride Chemical compound Cl.N=N RNOJZAYWQCKGRK-UHFFFAOYSA-N 0.000 description 1
FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
230000006806 disease prevention Effects 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
CVCXSNONTRFSEH-UHFFFAOYSA-N docosa-2,4-dienoic acid Chemical compound CCCCCCCCCCCCCCCCCC=CC=CC(O)=O CVCXSNONTRFSEH-UHFFFAOYSA-N 0.000 description 1
KFEVDPWXEVUUMW-UHFFFAOYSA-N docosanoic acid Natural products CCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 KFEVDPWXEVUUMW-UHFFFAOYSA-N 0.000 description 1
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
229940079593 drug Drugs 0.000 description 1
238000001035 drying Methods 0.000 description 1
239000008344 egg yolk phospholipid Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
ORDGRJBWPGCHAO-PUODRLBUSA-N ethyl (4r)-4-(oxan-2-yloxy)-7-oxoheptanoate Chemical compound CCOC(=O)CC[C@@H](CCC=O)OC1CCCCO1 ORDGRJBWPGCHAO-PUODRLBUSA-N 0.000 description 1
FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
239000000284 extract Substances 0.000 description 1
201000005577 familial hyperlipidemia Diseases 0.000 description 1
239000012065 filter cake Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
239000011888 foil Substances 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
235000011087 fumaric acid Nutrition 0.000 description 1
239000008103 glucose Substances 0.000 description 1
125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
239000011261 inert gas Substances 0.000 description 1
229960004903 invert sugar Drugs 0.000 description 1
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
239000008101 lactose Substances 0.000 description 1
235000019626 lipase activity Nutrition 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
UKZCGMDMXDLAGZ-UHFFFAOYSA-M magnesium;2-methylpropane;bromide Chemical compound [Mg+2].[Br-].C[C-](C)C UKZCGMDMXDLAGZ-UHFFFAOYSA-M 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
235000013310 margarine Nutrition 0.000 description 1
239000003264 margarine Substances 0.000 description 1
229910052987 metal hydride Inorganic materials 0.000 description 1
150000004681 metal hydrides Chemical class 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
SCDGDIOOASKSME-QNKVVAGZSA-N methyl (2s,3s,5s)-2-ethyl-3-hydroxy-5-(oxan-2-yloxy)docosanoate Chemical compound CCCCCCCCCCCCCCCCC[C@@H](C[C@H](O)[C@H](CC)C(=O)OC)OC1CCCCO1 SCDGDIOOASKSME-QNKVVAGZSA-N 0.000 description 1
AZGKXHRTSVLLTI-JTDNENJMSA-N methyl (3r)-3-(oxan-2-yloxy)hept-6-enoate Chemical compound COC(=O)C[C@@H](CCC=C)OC1CCCCO1 AZGKXHRTSVLLTI-JTDNENJMSA-N 0.000 description 1
NLOBFGOFYTWAIQ-JTDNENJMSA-N methyl (4r)-4-(oxan-2-yloxy)-7-oxoheptanoate Chemical compound COC(=O)CC[C@@H](CCC=O)OC1CCCCO1 NLOBFGOFYTWAIQ-JTDNENJMSA-N 0.000 description 1
IBUNOEXEHUNASK-PISNEZEASA-N methyl (z,3s)-3-hydroxyicos-11-enoate Chemical compound CCCCCCCC\C=C/CCCCCCC[C@H](O)CC(=O)OC IBUNOEXEHUNASK-PISNEZEASA-N 0.000 description 1
QLKIRIJPLOZMMY-DJUCYVQHSA-N methyl (z,3s,5s)-3-hydroxy-5-(oxan-2-yloxy)docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCC[C@@H](C[C@H](O)CC(=O)OC)OC1CCCCO1 QLKIRIJPLOZMMY-DJUCYVQHSA-N 0.000 description 1
HBVHDPSYAJZFEF-UHFFFAOYSA-N methyl 2-acetyloctanoate Chemical compound CCCCCCC(C(C)=O)C(=O)OC HBVHDPSYAJZFEF-UHFFFAOYSA-N 0.000 description 1
HVVZNBBKHPHBRW-UHFFFAOYSA-N methyl 2-hexyl-3-hydroxy-5-(oxan-2-yloxy)hexadecanoate Chemical compound CCCCCCCCCCCC(CC(O)C(CCCCCC)C(=O)OC)OC1CCCCO1 HVVZNBBKHPHBRW-UHFFFAOYSA-N 0.000 description 1
RYBPPYGMJPYBFL-UHFFFAOYSA-N methyl 2-hexyl-5-(oxan-2-yloxy)-3-oxohexadecanoate Chemical compound CCCCCCCCCCCC(CC(=O)C(CCCCCC)C(=O)OC)OC1CCCCO1 RYBPPYGMJPYBFL-UHFFFAOYSA-N 0.000 description 1
LCYXCWLJSOHFFX-UHFFFAOYSA-N methyl 2-hexyl-5-hydroxy-3-oxohexadecanoate Chemical compound CCCCCCCCCCCC(O)CC(=O)C(C(=O)OC)CCCCCC LCYXCWLJSOHFFX-UHFFFAOYSA-N 0.000 description 1
JMANFENOVOAFTJ-UHFFFAOYSA-N methyl 3-(oxan-2-yloxy)tetradecanoate Chemical compound CCCCCCCCCCCC(CC(=O)OC)OC1CCCCO1 JMANFENOVOAFTJ-UHFFFAOYSA-N 0.000 description 1
UOZZAMWODZQSOA-UHFFFAOYSA-N methyl 3-hydroxytetradecanoate Chemical compound CCCCCCCCCCCC(O)CC(=O)OC UOZZAMWODZQSOA-UHFFFAOYSA-N 0.000 description 1
WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
238000002156 mixing Methods 0.000 description 1
125000000896 monocarboxylic acid group Chemical group 0.000 description 1
125000001196 nonadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
235000006408 oxalic acid Nutrition 0.000 description 1
238000005949 ozonolysis reaction Methods 0.000 description 1
125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
HVAMZGADVCBITI-UHFFFAOYSA-N pent-4-enoic acid Chemical compound OC(=O)CCC=C HVAMZGADVCBITI-UHFFFAOYSA-N 0.000 description 1
125000003884 phenylalkyl group Chemical group 0.000 description 1
UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
MERGMNQXULKBCH-UHFFFAOYSA-N pyran-2,4-dione Chemical compound O=C1CC(=O)C=CO1 MERGMNQXULKBCH-UHFFFAOYSA-N 0.000 description 1
125000000719 pyrrolidinyl group Chemical group 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
238000010992 reflux Methods 0.000 description 1
238000007363 ring formation reaction Methods 0.000 description 1
230000000630 rising effect Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000012312 sodium hydride Substances 0.000 description 1
229910000104 sodium hydride Inorganic materials 0.000 description 1
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
125000003375 sulfoxide group Chemical group 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
WBWWGRHZICKQGZ-HZAMXZRMSA-N taurocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 WBWWGRHZICKQGZ-HZAMXZRMSA-N 0.000 description 1
AWDRATDZQPNJFN-VAYUFCLWSA-N taurodeoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 AWDRATDZQPNJFN-VAYUFCLWSA-N 0.000 description 1
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
RGRAUZKPLRNLEB-UTJQPWESSA-N tert-butyl (11z,14z)-3-(oxan-2-yloxy)icosa-11,14-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(CC(=O)OC(C)(C)C)OC1CCCCO1 RGRAUZKPLRNLEB-UTJQPWESSA-N 0.000 description 1
GYZMWQRWLVRBEL-UTJQPWESSA-N tert-butyl (13z,16z)-2-benzyl-3-hydroxy-5-(oxan-2-yloxy)docosa-13,16-dienoate Chemical compound C1CCCOC1OC(CCCCCCC\C=C/C\C=C/CCCCC)CC(O)C(C(=O)OC(C)(C)C)CC1=CC=CC=C1 GYZMWQRWLVRBEL-UTJQPWESSA-N 0.000 description 1
XXWVSMYCVRDJOO-PSDZMVHGSA-N tert-butyl (3r)-3-(oxan-2-yloxy)tetradecanoate Chemical compound CCCCCCCCCCC[C@H](CC(=O)OC(C)(C)C)OC1CCCCO1 XXWVSMYCVRDJOO-PSDZMVHGSA-N 0.000 description 1
YYZKKCVNAPQHEP-OTDUKCBNSA-N tert-butyl (z,3r)-3-hydroxyicos-11-enoate Chemical compound CCCCCCCC\C=C/CCCCCCC[C@@H](O)CC(=O)OC(C)(C)C YYZKKCVNAPQHEP-OTDUKCBNSA-N 0.000 description 1
SCSLUABEVMLYEA-UHFFFAOYSA-N tert-butyl pentanoate Chemical compound CCCCC(=O)OC(C)(C)C SCSLUABEVMLYEA-UHFFFAOYSA-N 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000001993 wax Substances 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
- C07D305/12—Beta-lactones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Polyesters Or Polycarbonates (AREA)

CS859016A 1984-12-21 1985-12-09 Process for preparing new derivatives of 4-/2-hydroxyethyl/-2-oxetanes CS262425B2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH610284		1984-12-21
CH393485		1985-09-12

Publications (1)

Publication Number	Publication Date
CS262425B2 true CS262425B2 (en)	1989-03-14

Family

ID=25694219

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CS859016A CS262425B2 (en)	1984-12-21	1985-12-09	Process for preparing new derivatives of 4-/2-hydroxyethyl/-2-oxetanes

Country Status (20)

Country	Link
US (2)	US4931463A (fr)
EP (1)	EP0185359B1 (fr)
CN (1)	CN1012643B (fr)
AT (1)	ATE70061T1 (fr)
AU (1)	AU583569B2 (fr)
CA (1)	CA1270837A (fr)
CS (1)	CS262425B2 (fr)
DE (1)	DE3584829D1 (fr)
DK (1)	DK166724B1 (fr)
DO (1)	DOP1985004386A (fr)
FI (1)	FI91403C (fr)
HU (1)	HU200172B (fr)
IE (1)	IE58926B1 (fr)
IL (1)	IL77338A (fr)
MC (1)	MC1728A1 (fr)
NO (1)	NO171160C (fr)
NZ (1)	NZ214565A (fr)
PH (1)	PH26291A (fr)
PT (1)	PT81748B (fr)
ZW (1)	ZW20385A1 (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1328881C (fr) *	1984-12-21	1994-04-26	Pierre Barbier	Procede pour la fabrication d'oxetanones
US5246960A (en) *	1984-12-21	1993-09-21	Hoffmann-La Roche Inc.	Oxetanones
US4895973A (en) *	1986-08-14	1990-01-23	G. D. Searle & Company	Substituted glutaric acid lactones in the treatment of hyperlipidemia
US4806564A (en) *	1987-05-26	1989-02-21	Merck & Co., Inc.	Antihypercholesterolemic beta-lactones
US4816477A (en) *	1987-05-26	1989-03-28	Merck & Co., Inc.	Antihypercholesterolemic β-lactones
CA2035972C (fr) *	1990-02-23	2006-07-11	Martin Karpf	Procede de preparation d'oxetanones
US5260310A (en) *	1990-02-26	1993-11-09	Hoffmann-La Roche Inc.	Oxetanone compounds and pharmaceutical compositions containing them
CA2098167C (fr) *	1992-06-24	2006-12-19	Dorothea Isler	Aliments pour humains et animaux contenant un inhibiteur de la lipase
BR9807655A (pt) *	1997-02-05	2000-02-15	Hoffmann La Roche	Uso de inibidores de lipase gastrintestinal.
ATE422359T1 (de)	1997-04-15	2009-02-15	Csir	Verbindungen und pharmazeutische zusammensetzungen mit appetitunterdrückender aktivität
GB2396815B (en) *	1999-10-27	2004-09-08	Phytopharm Plc	A composition comprising a pregnenone derivative and an NSAID
CA2358921A1 (fr) *	1999-10-29	2001-05-10	John Jason Gentry Mullins	Derives d'oxetanone
EP1132389A1 (fr)	2000-03-06	2001-09-12	Vernalis Research Limited	Nouveaux dérivés de l'azaindole pour le traitement de l'obésité
GB2363985B (en) *	2000-06-30	2004-09-29	Phytopharm Plc	Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
BR0112800A (pt)	2000-07-28	2003-07-01	Hoffmann La Roche	Utilização de um inibidor de lìpases e de um sequestrante de ácido de bìlis farmaceuticamente aceitáveis e processo para a prevenção e tratamento de enfermidades associadas com altos nìveis de colesterol de plasma
CA2417607C (fr)	2000-08-09	2008-01-29	Christine Feinle	Utilisation d'inhibiteurs de lipase
US6900226B2 (en)	2000-09-06	2005-05-31	Hoffman-La Roche Inc.	Neuropeptide Y antagonists
JP4047723B2 (ja)	2000-10-16	2008-02-13	エフ．ホフマン−ラロシュアーゲー	インドリン誘導体、および５−ｈｔ２受容体リガンドとしてのその使用
US6392061B1 (en) *	2000-10-16	2002-05-21	Zpro Chemical, Inc.	Process for making (2S, 3S, 5S) oxetanone derivatives
GB0030710D0 (en)	2000-12-15	2001-01-31	Hoffmann La Roche	Piperazine derivatives
EP1347979B1 (fr)	2000-12-27	2007-08-08	F. Hoffmann-La Roche Ag	Derives d'indole et leur utilisation en tant que ligands de recepteurs 5-ht2b et 5-ht2c
GB0106177D0 (en)	2001-03-13	2001-05-02	Hoffmann La Roche	Piperazine derivatives
KR100621287B1 (ko)	2001-05-21	2006-09-13	에프. 호프만-라 로슈 아게	신경 펩타이드 ｙ 수용체에 대한 리간드로서의 퀴놀린유도체
US6730319B2 (en)	2001-06-06	2004-05-04	Hoffmann-La Roche Inc.	Pharmaceutical compositions having depressed melting points
US20030027786A1 (en)	2001-06-06	2003-02-06	Karsten Maeder	Lipase inhibiting composition
US6787558B2 (en)	2001-09-28	2004-09-07	Hoffmann-La Roche Inc.	Quinoline derivatives
GB0202015D0 (en)	2002-01-29	2002-03-13	Hoffmann La Roche	Piperazine Derivatives
JP4216196B2 (ja)	2002-02-04	2009-01-28	エフ．ホフマン−ラロシュアーゲー	Ｎｐｙアンタゴニストとしてのキノリン誘導体
RU2004129285A (ru)	2002-02-28	2005-10-27	Ф.Хоффманн-Ля Рош Аг (Ch)	Производные тиазола в качестве антагонистов рецептора npy
US7728153B2 (en)	2002-04-17	2010-06-01	The Burnham Institute For Medical Research	Method for the asymmetric synthesis of beta-lactone compounds
AU2003226370A1 (en)	2002-04-17	2003-11-03	The Burnham Institute	Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation
EP1560816A1 (fr)	2002-07-05	2005-08-10	F. Hoffmann-La Roche Ag	Derives de quinazoline
AU2003253364B2 (en)	2002-08-07	2007-06-07	F. Hoffmann-La Roche Ag	Thiazole derivatives
NZ537979A (en)	2002-09-12	2007-08-31	Hoffmann La Roche	N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists useful for the treatment of diabetes
US6727277B1 (en)	2002-11-12	2004-04-27	Kansas State University Research Foundation	Compounds affecting cholesterol absorption
MXPA05005445A (es)	2002-11-25	2005-08-26	Hoffmann La Roche	Derivados de indolilo.
GB0314967D0 (en)	2003-06-26	2003-07-30	Hoffmann La Roche	Piperazine derivatives
WO2005005403A2 (fr) *	2003-07-15	2005-01-20	Ranbaxy Laboratories Limited	Procede de preparation d'oxetan-2-ones
RU2006107444A (ru)	2003-08-12	2007-09-20	Ф.Хоффманн-Ля Рош Аг (Ch)	2-амино-5-бензоилтиазолы в качестве антагонистов npy
CA2533464A1 (fr)	2003-08-12	2005-02-17	F. Hoffmann-La Roche Ag	Derives de thiazole utiles comme antagonistes de npy *
US7074822B2 (en) *	2004-02-23	2006-07-11	Solvay Pharmaceuticals Gmbh	Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
DE102004009076A1 (de) *	2004-02-23	2005-10-27	Solvay Pharmaceuticals Gmbh	Alkylcarbamat-substituierte β-Lactone, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US7121355B2 (en) *	2004-09-21	2006-10-17	Cnh America Llc	Bulldozer autograding system
WO2006035296A1 (fr) *	2004-09-27	2006-04-06	Ranbaxy Laboratories Limited	Procede de preparation d'un derive d'orlistat utile comme standard de reference dans la determination de la purete d'orlistat et procede de preparation d'orlistat
AU2006243243B2 (en)	2005-05-03	2009-05-14	F. Hoffmann-La Roche Ag	Tetracyclic azapyrazinoindolines as 5-HT2 ligands
EP1945635B1 (fr)	2005-08-18	2009-05-06	F.Hoffmann-La Roche Ag	Derives de thiazolyle piperidine utile comme modulateurs du recepteur h3
US20090171104A1 (en) *	2005-10-05	2009-07-02	Killol Patel	Process for the preparation of orlistat
WO2007062999A2 (fr)	2005-11-30	2007-06-07	F. Hoffmann-La Roche Ag	Derives de indole-2-yl amide substitues en 1,5
EP1968967B1 (fr)	2005-11-30	2011-04-27	F. Hoffmann-La Roche AG	Derives de 1,1-dioxo-thiomorpholinyl indolylmethanone utilises comme modulateurs des recepteurs h3
WO2007063000A1 (fr)	2005-11-30	2007-06-07	F. Hoffmann-La Roche Ag	Derives de indole-2-carboxamide substitues en 5
WO2007065820A1 (fr)	2005-12-09	2007-06-14	F. Hoffmann-La Roche Ag	Dérivés d’amides tricycliques utiles pour le traitement de l’obésité
WO2007068620A1 (fr)	2005-12-15	2007-06-21	F. Hoffmann-La Roche Ag	Derives de pyrrolo[2,3-c]pyridine
JP2009519293A (ja)	2005-12-16	2009-05-14	エフ．ホフマン−ラロシュアーゲー	Ｈ３レセプター調節剤としてのピロロ［２，３−ｂ］ピリジン誘導体
CA2635719A1 (fr) *	2006-01-13	2007-07-19	F. Hoffmann-La Roche Ag	Derives de methanone de type cyclohexyle et piperazinyle et leur application en tant que modulateurs du recepteur h3 de l'histamine
DE602007008831D1 (de) *	2006-01-23	2010-10-14	Hoffmann La Roche	Cyclohexyl-sulfonamid-derivate mit h3-rezeptoraktivität
US7432255B2 (en)	2006-05-16	2008-10-07	Hoffmann-La Roche Inc.	1H-indol-5-yl-piperazin-1-yl-methanone derivatives
US7902184B2 (en) *	2006-05-30	2011-03-08	Hoffmann-La Roche Inc.	Piperazinyl pyrimidine derivatives
US7514433B2 (en)	2006-08-03	2009-04-07	Hoffmann-La Roche Inc.	1H-indole-6-yl-piperazin-1-yl-methanone derivatives
US20080146559A1 (en)	2006-12-08	2008-06-19	Li Chen	4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives
SG182171A1 (en) *	2007-06-06	2012-07-30	Ranbaxy Lab Ltd	Process for the preparation of orlistat
EP2183237A1 (fr)	2007-07-25	2010-05-12	F. Hoffmann-Roche AG	Dérivés d'amide d'acide benzofurane- et benzo[b]thiophène-2-carboxylique et leur utilisation comme modulateurs du récepteur h3 de l'histamine
CA2704462A1 (fr) *	2007-10-31	2009-05-07	Burnham Institute For Medical Research	Composes de beta-lactone
WO2010112569A1 (fr)	2009-03-31	2010-10-07	Robert Zimmermann	Modulation de lipase de triglycérides d'adipose pour la prévention et le traitement d'une cachexie, d'une perte de poids et d'une atrophie musculaire et procédés de criblage s'y rapportant
US8993509B2 (en)	2009-03-31	2015-03-31	Robert Zimmerman	Method for treatment of cachexia by administering inhibitors of adipose triglyceride lipase expression or activity
US8450350B2 (en)	2010-05-05	2013-05-28	Infinity Pharmaceuticals, Inc.	Triazoles as inhibitors of fatty acid synthase
WO2011140190A1 (fr)	2010-05-05	2011-11-10	Infinity Pharmaceuticals	Tétrazolones utilisés en tant qu'inhibiteurs d'acide gras synthase (fasn)
KR102679975B1 (ko) *	2017-07-12	2024-06-28	메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치	지방독성 손상을 저감하기 위한 화합물
CN112079821A (zh) *	2020-09-14	2020-12-15	中山万汉制药有限公司	奥利司他与苯氨基嘧啶类化合物形成的缀合物及其制备方法与用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2478388A (en) *	1945-09-28	1949-08-09	Eastman Kodak Co	beta-lactones from unsaturated aldehydes and unsaturated ketones
JPS608117B2 (ja) *	1977-02-08	1985-02-28	財団法人微生物化学研究会	新生理活性物質エステラスチンおよびその製造法
GB2023604B (en) *	1978-05-25	1982-07-28	Microbial Chem Res Found	Physiologically active derivatives of esterastin and production thereof
JPS56128774A (en) *	1980-03-14	1981-10-08	Microbial Chem Res Found	New physiologically active substance ebelactone and its preparation
CA1247547A (fr) *	1983-06-22	1988-12-28	Paul Hadvary	Derives de leucine

1985
- 1985-11-12 CA CA000495058A patent/CA1270837A/fr not_active Expired - Lifetime
- 1985-11-15 ZW ZW203/85A patent/ZW20385A1/xx unknown
- 1985-12-04 FI FI854797A patent/FI91403C/fi not_active IP Right Cessation
- 1985-12-09 CS CS859016A patent/CS262425B2/cs not_active IP Right Cessation
- 1985-12-16 NZ NZ214565A patent/NZ214565A/xx unknown
- 1985-12-16 IL IL77338A patent/IL77338A/xx not_active IP Right Cessation
- 1985-12-16 AU AU51259/85A patent/AU583569B2/en not_active Expired
- 1985-12-17 EP EP85116096A patent/EP0185359B1/fr not_active Expired - Lifetime
- 1985-12-17 AT AT85116096T patent/ATE70061T1/de not_active IP Right Cessation
- 1985-12-17 DE DE8585116096T patent/DE3584829D1/de not_active Expired - Lifetime
- 1985-12-18 PH PH33205A patent/PH26291A/en unknown
- 1985-12-18 HU HU854832A patent/HU200172B/hu unknown
- 1985-12-18 MC MC851814A patent/MC1728A1/fr unknown
- 1985-12-19 CN CN85108888A patent/CN1012643B/zh not_active Expired
- 1985-12-20 NO NO855213A patent/NO171160C/no not_active IP Right Cessation
- 1985-12-20 PT PT81748A patent/PT81748B/pt unknown
- 1985-12-20 DK DK600385A patent/DK166724B1/da not_active IP Right Cessation
- 1985-12-20 IE IE327785A patent/IE58926B1/en not_active IP Right Cessation
- 1985-12-30 DO DO1985004386A patent/DOP1985004386A/es unknown
1987
- 1987-12-17 US US07/134,322 patent/US4931463A/en not_active Expired - Lifetime
1990
- 1990-03-19 US US07/495,809 patent/US5175186A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DK600385A (da)	1986-06-22
IE58926B1 (en)	1993-12-01
IL77338A (en)	1991-04-15
FI854797A7 (fi)	1986-06-22
CA1270837A (fr)	1990-06-26
DK600385D0 (da)	1985-12-20
ZW20385A1 (en)	1986-03-05
FI854797A0 (fi)	1985-12-04
NZ214565A (en)	1989-06-28
NO171160B (no)	1992-10-26
PT81748B (pt)	1988-07-29
US4931463A (en)	1990-06-05
DE3584829D1 (de)	1992-01-16
CN85108888A (zh)	1986-07-09
HUT39440A (en)	1986-09-29
ATE70061T1 (de)	1991-12-15
FI91403C (fi)	1994-06-27
EP0185359A2 (fr)	1986-06-25
AU5125985A (en)	1986-06-26
EP0185359B1 (fr)	1991-12-04
DK166724B1 (da)	1993-07-05
CN1012643B (zh)	1991-05-22
EP0185359A3 (en)	1987-08-26
HU200172B (en)	1990-04-28
IE853277L (en)	1986-06-21
AU583569B2 (en)	1989-05-04
US5175186A (en)	1992-12-29
NO855213L (no)	1986-06-23
FI91403B (fi)	1994-03-15
PT81748A (en)	1986-01-02
NO171160C (no)	1993-02-03
MC1728A1 (fr)	1986-12-15
DOP1985004386A (es)	1991-04-20
PH26291A (en)	1992-04-10

Legal Events

Date	Code	Title	Description
2000-06-30	IF00	In force as of 2000-06-30 in czech republic
2001-02-14	MK4A	Patent expired	Effective date: 20001209

Publication	Publication Date	Title
US5175186A (en)	1992-12-29	Oxetanones
US5246960A (en)	1993-09-21	Oxetanones
US4983746A (en)	1991-01-08	Oxetanones and process for their production
Clive et al.	1990	Total synthesis of both (+)-compactin and (+)-mevinolin. A general strategy based on the use of a special titanium reagent for dicarbonyl coupling
HU208686B (en)	1993-12-28	Process for producing oxetanones
DE19645362A1 (de)	1998-04-30	Verfahren zur Herstellung von Epothilon A und B und Derivaten
US4503072A (en)	1985-03-05	Antihypercholesterolemic compounds
WO1995033716A1 (fr)	1995-12-14	Derive de la vitamine d3 et son procede de production
CS235329B2 (en)	1985-05-15	Method of 3-oxa-6a-carbaprostaglandine i 2 derivatives production
DK159313B (da)	1990-10-01	Analogifremgangsmaade til fremstilling af 5-cyanoprostacyklinderivater
KR950008310B1 (ko)	1995-07-27	옥세타논의 제조방법
JPH05178849A (ja)	1993-07-20	光学活性な含フッ素化合物
EP0164698B1 (fr)	1989-07-19	Procédé d'épimérisation sur le carbone 6 de 3,4,5,6-tétrahydro-2H-pyranne-2-one
Tadano et al.	1990	Stereoselectivity in the ortho ester Claisen rearrangements of the E and Z isomers of. gamma.-(1, 3-dioxan-4-yl) allyl alcohols
US4472426A (en)	1984-09-18	Antihypercholesterolemic compounds
US7122686B2 (en)	2006-10-17	Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
JPH0735365B2 (ja)	1995-04-19	カルシフエロ−ル誘導体
Kazmaier et al.	1998	A short synthesis of polyhydroxylated piperidines by aldol reaction of chelated amino acid ester enolates
CS271479B2 (en)	1990-10-12	Method of alpha-hydroxy-bicyclo/3,3,0/octane's derivatives production
US5849749A (en)	1998-12-15	6-(hydroxymethyl-ethyl)pyridines
US4526991A (en)	1985-07-02	2,6-Dioxa-bicyclo-[2,2,2]-octane-7-yl-acetaldehydes
Kametani et al.	1986	Novel construction of penem ring system from penicillin derivatives. Synthesis of a 2-carboxypenem derivative
Mukaiyama et al.	1986	A stereocontrolled synthesis of 2, 3, 5-trisubstituted tetrahydrofurans from aldolized γ-diketones via cyclization-reduction process
JPH041148A (ja)	1992-01-06	光学活性なアルケニル置換ヘプタン誘導体
Ikegami et al.	1992	Stereoselective Synthesis of (.+-.)-Ireland Alcohol Using Titanium-Mediated (2, 3) Wittig Rearrangement Product as a Starting Material.